Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.70%71.9B | 0.40%309.56B | 2.84%75.45B | 7.95%308.34B | 5.74%76.46B | 7.40%80.69B | 5.52%77.83B | 13.84%73.37B | 9.40%285.64B | 0.38%72.3B |
| Cost of revenue | -7.31%57.93B | -1.71%250.14B | -0.20%62.5B | 5.65%254.49B | 2.39%61.17B | 4.62%65.89B | 3.46%64.81B | 12.81%62.62B | 13.01%240.87B | 2.77%59.74B |
| Gross profit | 7.90%13.97B | 10.36%59.43B | 20.50%12.95B | 20.29%53.85B | 21.71%15.29B | 21.80%14.79B | 17.10%13.02B | 20.21%10.75B | -6.63%44.77B | -9.60%12.56B |
| Operating expense | 2.19%9.06B | -45.76%37.58B | 6.38%8.87B | 92.42%69.29B | 238.36%42.25B | 37.84%9.7B | 4.92%9B | 5.41%8.34B | 21.58%36.01B | 52.11%12.49B |
| Selling and administrative expenses | 2.31%9.22B | -2.44%36.51B | 7.26%9.01B | 13.77%37.43B | 25.37%10.32B | 16.68%9.67B | 9.55%9.03B | 3.33%8.4B | 7.34%32.9B | 1.99%8.23B |
| -General and administrative expense | 2.31%9.22B | -2.44%36.51B | 7.26%9.01B | 13.77%37.43B | 25.37%10.32B | 16.68%9.67B | 9.55%9.03B | 3.33%8.4B | 7.34%32.9B | 1.99%8.23B |
| Other operating expenses | -68.25%87M | -84.88%5.02B | 34.98%274M | 498.65%33.19B | 603.57%32.51B | 0.38%266M | -63.06%208M | 111.46%203M | 432.56%5.54B | 591.77%4.62B |
| Total other operating income | -41.69%242M | 197.74%3.95B | 56.02%415M | -45.45%1.33B | 58.47%580M | -84.08%242M | 4.37%239M | -15.82%266M | 17.33%2.43B | -30.94%366M |
| Operating profit | 20.30%4.91B | 241.51%21.85B | 69.25%4.08B | -276.25%-15.44B | -36,539.19%-26.97B | -0.27%5.1B | 58.25%4.02B | 133.37%2.41B | -52.21%8.76B | -98.70%74M |
| Net non-operating interest income (expenses) | -160.40%-819M | -140.33%-853M | 19.79%1.36B | 92.62%2.12B | 390.41%1.06B | 45.14%-559M | -50.57%480M | -25.03%1.13B | -1.88%1.1B | -164.49%-365M |
| Non-operating interest income | -91.02%142M | -82.33%579M | 14.32%1.58B | 52.49%3.28B | 3,697.44%1.4B | 39.24%110M | -39.30%743M | -20.24%1.38B | 3.32%2.15B | -104.83%-39M |
| Non-operating interest expense | 327.11%961M | 23.24%1.43B | -10.36%225M | 10.56%1.16B | 5.21%343M | -39.07%669M | 3.95%263M | 12.05%251M | 9.37%1.05B | 35.27%326M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 376.92%62M | -1,276.00%-588M | -31.58%13M | -12.28%50M | 500.00%4M | -6.67%14M | -27.78%13M | -24.00%19M | 185.00%57M | -200.00%-1M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -23.79%4.16B | 253.72%20.41B | 52.96%5.45B | -233.86%-13.27B | -8,862.28%-25.9B | 10.81%4.55B | 27.83%4.51B | 38.82%3.57B | -49.06%9.92B | -104.62%-289M |
| Income tax | -39.83%1.05B | 252.89%6.4B | 153.63%1.75B | -189.40%-4.18B | -541.64%-7.98B | 57.17%1.62B | 41.28%1.48B | -13.24%688M | -17.09%4.68B | -3.83%1.81B |
| Net income | -16.21%3.11B | 254.09%14.01B | 28.85%3.71B | -273.61%-9.09B | -755.61%-17.93B | -4.78%2.93B | 22.14%3.03B | 62.08%2.88B | -62.12%5.24B | -147.90%-2.1B |
| Net income continuous operations | -16.24%3.11B | 254.10%14.01B | 28.88%3.71B | -273.61%-9.09B | -755.61%-17.93B | -4.75%2.93B | 22.14%3.03B | 62.08%2.88B | -62.12%5.24B | -147.90%-2.1B |
| Noncontrolling interests | 117.42%387M | 35.48%1.26B | -36.20%178M | 44.43%933M | 52.76%304M | 57.63%93M | 77.93%258M | 14.81%279M | -51.97%646M | -51.23%199M |
| Net income attributable to the company | -22.95%2.72B | 227.15%12.74B | 35.84%3.53B | -318.32%-10.02B | -694.98%-18.23B | -5.97%2.84B | 18.67%2.77B | 69.58%2.6B | -63.20%4.59B | -157.82%-2.29B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -22.95%2.72B | 227.15%12.74B | 35.84%3.53B | -318.32%-10.02B | -694.98%-18.23B | -5.97%2.84B | 18.67%2.77B | 69.58%2.6B | -63.20%4.59B | -157.82%-2.29B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -2.88%74.41 | 242.50%304.13 | 38.45%76.62 | -318.28%-213.43 | -694.45%-388.17 | -5.99%60.4 | 18.62%59 | 69.49%55.34 | -63.23%97.78 | -157.82%-48.86 |
| Diluted earnings per share | -2.88%74.41 | 242.50%304.13 | 38.45%76.62 | -318.28%-213.43 | -694.45%-388.17 | -5.99%60.4 | 18.62%59 | 69.49%55.34 | -63.23%97.78 | -157.82%-48.86 |
| Dividend per share | 0 | 108.33%250 | 0 | 33.33%120 | 33.33%60 | 0 | 33.33%60 | 0 | 0.00%90 | -10.00%45 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |